Page last updated: 2024-10-31

midazolam and Argentaffinoma

midazolam has been researched along with Argentaffinoma in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jabbour-Khoury, S1
Dabbous, A1
al-Jazzar, M1
Rizk, M1
Chahine, M1
Khalife, M1
Ayoub, C1
Baraka, A1
Hudcova, J1
Schumann, R1

Other Studies

2 other studies available for midazolam and Argentaffinoma

ArticleYear
Anesthetic management of a patient having a carcinoid syndrome.
    Middle East journal of anaesthesiology, 2003, Volume: 17, Issue:3

    Topics: Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Atracurium; Carcinoid Tumor; Fema

2003
Undiagnosed catecholamine-secreting paraganglioma and coexisting carcinoid in a patient with MH susceptibility: an unusual anesthetic challenge.
    Journal of anesthesia, 2007, Volume: 21, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenou

2007